Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ADUKKIPA74

Financiado

Cerrado

In Meso Crystallogenesis of GPCR protein ligand complexes

G protein-coupled receptor (GPCR) proteins are the single largest drug target, representing 30% of all marketed drugs. All GPCRs share a basic structural core of seven transmembrane alpha-helical domains. In spite of this similari... ver más

31/07/2012

TRINITY COLLEGE DU...

239K€

Presupuesto del proyecto: 239K€

Líder del proyecto

THE PROVOST FELLOWS FOUNDATION SCHOLARS THE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2012-07-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

TRINITY COLLEGE DUBLIN

0.00€ | Lider

Proyectos interesantes

ADORA

Medical Technol...

Applied Physics

100K€ Cerrado

MEGAKINE

Medical Technol...

Applied Physics

178K€ Cerrado

EMPSI

Medical Technol...

Applied Physics

2M€ Cerrado

Adrenergic receptors

Medical Technol...

Applied Physics

186K€ Cerrado

SIGT-OR-G

Medical Technol...

Applied Physics

139K€ Cerrado

TUDOR

Medical Technol...

Applied Physics

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

THE PROVOST FELLOWS FOUNDATION SCHOLARS THE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 239K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto G protein-coupled receptor (GPCR) proteins are the single largest drug target, representing 30% of all marketed drugs. All GPCRs share a basic structural core of seven transmembrane alpha-helical domains. In spite of this similarity, GPCRs have evolved to be extremely versatile receptors for extracellular messengers as diverse as biogenic amines, purines and nucleic acid derivatives, lipids, peptides and proteins, odorants, pheromones, tastants, ions like calcium and protons, and even photons. Due to their significant effect on human physiology and disease, it is crucial to understand from a structural biology perspective, the molecular basis for the interaction between a GPCR and its ligand. The recent success in the structure determination of the Beta2-adrenergic GPCR and the adenosine A2a GPCR using the in meso crystallization methodolgy paves the way for further advances in structure determination of GPCR structures. As of today, there is no structural information available that helps us in understanding the molecular basis of interaction between a GPCR and its protein ligand. In this application, we propose to perform structure-function studies on two GPCRs, CXCR4 and Formyl Peptide Receptor, that are activated by the polypeptides SDF1 and f-MLF respectively. We propose to use in a synergistic fashion two novel methodologies, the BACMAM system and in meso crystallography, to express, purify and crystallize complexes between CXCR4-SDF1 and FPR-fMLF. Information obtained from the structure determination of these complexes would go a long way in helping us understand the molecular mechanisms responsible for the signal transduction properties of GPCRs that are activated by protein ligands. In addition, this information would also help us in designing and developing better drugs aimed at treating cancer metastases, AIDS and Parkinsons disease.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores